As per the study initiated by Evolve Business Intelligence, The global Human Microbiome market size is expected to reach $1,907.68 Million by 2028 growing at the CAGR of 21.34% from 2021 to 2028. Some of the major factor impacting the overall growth of Human Microbiome market include, increase in funding from government, focus on developing of human microbiome therapeutics, rapid growth in lifestyle related disease and growing aged population. The major factor that are restraining the growth includes the lack of knowledge in these field and lack of research initiative by various players.
Analyst's View
According Parimal, “the pandemic had forced different government to focus on the development of drug around the world. Due to the increasing prevalence of disease around the world, the government is focusing on the development of drug with the help of human microbiome. Various government had initiated program to support the pharmaceuticals companies.”
ENTEROME Bioscience to hold the highest market share in Reception Robotics
The Human Microbiome market has witnessed several new additions to the number of players offering the product. Some of these are ENTEROME Bioscience, Seres Therapeutics, 4D pharma, Evelo Biosciences, OptiBiotix Health.
The Human Microbiome market report published today include market revenue generated through the sale of product such as Probiotics, Prebiotics, Diagnostic Tests, Drugs, and Other Products. The report includes the analysis of the market on the basis of technology such as, Genomics, Sequencing (16s rRNA sequencing method, Whole-genome sequencing method, Other Sequencing methods, Other Genomic Technologies), Proteomics, Metabolomics. The report includes analysis of market on disease such as Infectious Diseases, Endocrine and Metabolic Disorders, Gastrointestinal Diseases, Cancer, and Other Diseases. The report also includes the analysis of market on basis of application such as therapeutics and diagnostics
